ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 DiabetesMichael Brines, Albert Dahan, Monique van Velzen et al.|Molecular Medicine|2014Cited by 143